NORMAN v. XYTEX CORPORATION

848 S.E.2d 835, 310 Ga. 127
CourtSupreme Court of Georgia
DecidedSeptember 28, 2020
DocketS19G1486
StatusPublished
Cited by30 cases

This text of 848 S.E.2d 835 (NORMAN v. XYTEX CORPORATION) is published on Counsel Stack Legal Research, covering Supreme Court of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NORMAN v. XYTEX CORPORATION, 848 S.E.2d 835, 310 Ga. 127 (Ga. 2020).

Opinion

310 Ga. 127 FINAL COPY

S19G1486. NORMAN et al. v. XYTEX CORPORATION et al.

PETERSON, Justice.

“Respect for life and the rights proceeding from it are at the

heart of our legal system and, broader still, our civilization.” Fulton-

DeKalb Hosp. Auth. v. Graves, 252 Ga. 441, 444 (3) (314 SE2d 653)

(1984) (quoting Cockrum v. Baumgartner, 447 NE2d 385, 389 (Ill.

1983)). For this reason, this Court has repeatedly refused to allow

damages in tort that necessarily presume that life itself can ever be

an injury. See, e.g., Etkind v. Suarez, 271 Ga. 352, 352-353 (1) (519

SE2d 210) (1999); Atlanta Obstetrics & Gynecology Group v. Abelson,

260 Ga. 711 (398 SE2d 557) (1990); Graves, 252 Ga. at 443-444 (3).

We reaffirm that rule today. But that rule does not fully resolve this

appeal, which is about what sort of damages the rule actually bars.

Wendy and Janet Norman allege that Xytex Corporation, a

sperm bank, sold them human sperm under false pretenses about

the characteristics of its donor, and that the child conceived with that sperm now suffers from a variety of impairments inherited from

the sperm donor. The Court of Appeals affirmed the dismissal of all

but one of the Normans’ claims on the basis of Etkind and Abelson.

See Norman v. Xytex Corp., 350 Ga. App. 731, 732-734 (830 SE2d

267) (2019). We granted certiorari and now hold that claims arising

from the very existence of the child are barred, but claims arising

from specific impairments caused or exacerbated by defendants’

alleged wrongs may proceed, as may other claims that essentially

amount to ordinary consumer fraud. We affirm in part, reverse in

part, and remand the case for further proceedings consistent with

the principles we explain herein.

1. Relevant facts of the case.

Because we are reviewing an order on a motion to dismiss, we

take the allegations in the complaint as true and resolve all doubts

in favor of the Normans. See Williams v. DeKalb County, 308 Ga.

265, 270 (2) (840 SE2d 423) (2020). In that light, Xytex represented

that it carefully screened the personal health, criminal history, and

family history of all donors; that donors were put through rigorous physical exams and interviews to confirm the accuracy of the

information donors provided; and that because of its thorough

screening process, fewer than five percent of candidates became

donors. Xytex also represented that it required sperm donors to

update their medical history every six months; that the company

would update the donors’ profiles with any new information; and

that, if the company received “medically significant” information

about a donor, it would notify patients who used that donor’s sperm.

Xytex promoted Donor #9623 as one of its “best” sperm donors on

account of his profile in which he represented that he was a Ph.D.

candidate with an IQ of 160 and had no history of mental health

issues or criminal activity.

On his Xytex questionnaire, Donor #9623 lied about his mental

health. Xytex never asked him to verify his answers, supply his

medical records, or sign a release for such records. Xytex also never

asked about his criminal history or asked him to provide any

identification. At Donor #9623’s initial visit, Xytex’s employee Mary

Hartley told him that intelligent donors with high levels of education were more popular sperm donors and encouraged Donor

#9623 to exaggerate his IQ and education. Although he claimed he

had advanced degrees, Donor #9623 had no degrees at all when he

completed his questionnaire.

During the time Donor #9623 sold sperm to Xytex, from 2000

to 2016, he was arrested for burglary, trespassing, DUI, and

disorderly conduct; he pleaded guilty to burglary in 2005.1 After a

lawsuit was filed against Xytex in 2014 concerning Donor #9623, he

provided Xytex with forged graduation diplomas that it accepted

without question.

Based on the representations that Xytex made regarding its

screening procedures and the representations made in Donor

#9623’s profile, the Normans purchased Donor #9623’s sperm.

Wendy was inseminated with the sperm, and she gave birth to a son,

A. A., in June 2002. Xytex was not involved in the insemination

1 The Normans do not specify in their complaint the dates of Donor #9623’s arrests for the other offenses. But viewing the allegations in the light most favorable to the Normans, we infer at this procedural posture that the arrests preceded the Normans’ use of Donor #9623’s sperm. process.

A. A. has been diagnosed with Attention Deficit Hyperactivity

Disorder and Thalassemia Minor, an inheritable blood disorder for

which Wendy is not a carrier. A. A. regularly has suicidal and

homicidal ideations, requiring multiple periods of extended

hospitalizations. A. A. regularly sees a therapist for his anger and

depression, and he takes ADHD, anti-depressant, and anti-

psychotic medications.

In March 2017, A. A. conducted an internet search on Donor

#9623, and he and the Normans discovered in publicly available

documents that the representations Xytex made regarding Donor

#9623 were false. In reviewing those documents and through

interviewing Donor #9623, the Normans learned that, before Donor

#9623 began selling his sperm to Xytex in 2000, he had been

hospitalized for mental health treatment and diagnosed with

psychotic schizophrenia, narcissistic personality disorder, and

significant grandiose delusions.

Following their discoveries, the Normans brought suit against Xytex (Xytex International and Xytex Corporation, a subsidiary),

Hartley, Xytex’s Medical Director J. Todd Spradlin, and a number

of John Does (collectively, the “Defendants”). The Normans raised

claims for fraud, negligent misrepresentation, products liability

and/or strict liability, products liability and/or negligence, breach of

express warranty, breach of implied warranty, battery, negligence,

unfair business practices, specific performance, false advertising,

promissory estoppel, and unjust enrichment. The Defendants filed a

motion to dismiss the complaint on various grounds, including on

the basis that the Normans were asserting “wrongful birth” claims

that are not legally recognized under Abelson. The trial court denied

the Defendants’ motion to dismiss in part and granted it in part,2

2 The trial court considered alternative grounds to dismiss the Normans’

claims, including statutes of limitations, but rejected the motion as to most of these alternative grounds. The trial court granted the Defendants’ motion to dismiss the Normans’ battery claim on the alternative ground that there was no allegation that any defendant ever touched or threatened to touch either plaintiff in a harmful, insulting, or provoking manner. The trial court also dismissed the Normans’ false advertising claim because the Normans were not seeking injunctive relief. The trial court also ruled that a claim based on a fear that A.A. might someday be diagnosed with schizophrenia was not sufficient to support an action for damages and dismissed a claim for such damages as unripe. These alternative rulings are not before us. concluding that all of the Normans’ claims for relief, with the

exception of the specific performance claim,3 were claims for

“wrongful birth camouflaged as some other tort.”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
S.D. Georgia, 2026
A.D.A. v. XYTEX CORPORATION
Court of Appeals of Georgia, 2026
CAMBRE & ASSOCIATES, LLC v. R. SHANE LAZENBY
Court of Appeals of Georgia, 2025
PRESTIGE NISSAN, INC. v. BROAD & CASSEL, LLP
Court of Appeals of Georgia, 2025
MICHAEL BLAND v. UROLOGY OF GREATER ATLANTA, LLC
Court of Appeals of Georgia, 2025
PIRS CAPITAL, LLC v. VIVACE DESIGN BUILD, INC.
Court of Appeals of Georgia, 2025
MAYRA NORRIS v. ATLANTA BRAVES, INC.
Court of Appeals of Georgia, 2025
Ag Resource Management, LLC v. Mundy, Inc.
Court of Appeals of Georgia, 2025
LANE L. FOWLER v. WBL SPO I, LLC
Court of Appeals of Georgia, 2025
PHOUNG T. NGUYEN v. BANK OF AMERICA CORPORATION
Court of Appeals of Georgia, 2025
Kennestone Hospital, Inc. v. Gregory P. Turner
Court of Appeals of Georgia, 2025
MORGAN & MORGAN JACKSONVILLE, PLLC v. BRIAN BROWN
Court of Appeals of Georgia, 2024
DEBORAH SIMMONS v. SOLO CUP OPERATING CORPORATION
Court of Appeals of Georgia, 2024
Eric Daniel Dial v. Reagan Amanda Burge
Court of Appeals of Georgia, 2024
Milliron v. Antonakakis
Supreme Court of Georgia, 2024
RONALD MCLEOD v. COSTCO WHOLESALE CORPORATION
Court of Appeals of Georgia, 2023
110 Hampton Point, LLC v. Thurman Ross, III
Court of Appeals of Georgia, 2023
SOUTHERN STATES CHEMICAL, INC. v. TAMPA TANK AND WELDING, INC
316 Ga. 701 (Supreme Court of Georgia, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
848 S.E.2d 835, 310 Ga. 127, Counsel Stack Legal Research, https://law.counselstack.com/opinion/norman-v-xytex-corporation-ga-2020.